Cuiqi Zhou

1.6k total citations
35 papers, 1.3k citations indexed

About

Cuiqi Zhou is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Cuiqi Zhou has authored 35 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Cancer Research. Recurrent topics in Cuiqi Zhou's work include Pituitary Gland Disorders and Treatments (8 papers), Growth Hormone and Insulin-like Growth Factors (6 papers) and Wnt/β-catenin signaling in development and cancer (5 papers). Cuiqi Zhou is often cited by papers focused on Pituitary Gland Disorders and Treatments (8 papers), Growth Hormone and Insulin-like Growth Factors (6 papers) and Wnt/β-catenin signaling in development and cancer (5 papers). Cuiqi Zhou collaborates with scholars based in United States, China and India. Cuiqi Zhou's co-authors include Шломо Мелмед, Ningzhi Xu, Hongxia Zhu, Yihua Wang, Run Yu, Kolja Wawrowsky, Deepti Dhall, Nicholas N. Nissen, Song-Guang Ren and Xiaobo Zhou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Cuiqi Zhou

35 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cuiqi Zhou United States 21 687 390 297 279 225 35 1.3k
Iván Plaza-Menacho United Kingdom 20 598 0.9× 240 0.6× 197 0.7× 490 1.8× 151 0.7× 27 1.3k
Gabriele Jaques Germany 19 609 0.9× 361 0.9× 204 0.7× 360 1.3× 54 0.2× 40 1.1k
Michele Menicagli Italy 19 543 0.8× 108 0.3× 245 0.8× 366 1.3× 157 0.7× 50 1.2k
Yen K. Lieu United States 16 674 1.0× 403 1.0× 136 0.5× 295 1.1× 413 1.8× 21 1.9k
Paul Naik United States 7 689 1.0× 186 0.5× 235 0.8× 308 1.1× 176 0.8× 8 1.0k
Paolo Salerno Italy 16 667 1.0× 379 1.0× 254 0.9× 410 1.5× 51 0.2× 31 1.1k
Nives Pećina‐Šlaus Croatia 18 810 1.2× 45 0.1× 261 0.9× 298 1.1× 147 0.7× 56 1.4k
J K Anderson United States 13 949 1.4× 350 0.9× 148 0.5× 212 0.8× 132 0.6× 21 1.4k
Cong S. Zong United States 17 825 1.2× 205 0.5× 168 0.6× 495 1.8× 53 0.2× 24 1.3k
Nicolas Gadot France 20 520 0.8× 85 0.2× 108 0.4× 197 0.7× 70 0.3× 46 990

Countries citing papers authored by Cuiqi Zhou

Since Specialization
Citations

This map shows the geographic impact of Cuiqi Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cuiqi Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cuiqi Zhou more than expected).

Fields of papers citing papers by Cuiqi Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cuiqi Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cuiqi Zhou. The network helps show where Cuiqi Zhou may publish in the future.

Co-authorship network of co-authors of Cuiqi Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Cuiqi Zhou. A scholar is included among the top collaborators of Cuiqi Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cuiqi Zhou. Cuiqi Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zonis, Svetlana, Cuiqi Zhou, Robert J. Barrett, et al.. (2023). WIP1 is a novel specific target for growth hormone action. iScience. 26(11). 108117–108117. 4 indexed citations
2.
Garcia, Pierre, Rashi Halder, Alessandro Michelucci, et al.. (2020). Pituitary Tumor Transforming Gene 1 Orchestrates Gene Regulatory Variation in Mouse Ventral Midbrain During Aging. Frontiers in Genetics. 11. 566734–566734. 3 indexed citations
3.
Zhou, Cuiqi, et al.. (2020). Integrated multi-omics profiling of nonfunctioning pituitary adenomas. Pituitary. 24(3). 312–325. 6 indexed citations
4.
Zhou, Cuiqi, Vivien Bonert, Adam N. Mamelak, et al.. (2019). MON-459 ONO-5788, a Novel Oral Small Molecule Somatostatin Receptor Type-2 (SST2) Agonist, Attenuates GH Hypersecretion in Human GH-Secreting, Pituitary Adenoma-Derived Cells. Journal of the Endocrine Society. 3(Supplement_1). 6 indexed citations
5.
Qin, Zhen, Vladimir A. Ljubimov, Cuiqi Zhou, Yunguang Tong, & Jimin Liang. (2016). Cell-free circulating tumor DNA in cancer. Chinese Journal of Cancer. 35(1). 36–36. 111 indexed citations
6.
Zhou, Cuiqi, Mei Liu, Yong Yao, et al.. (2015). MicroRNA involvement in a metastatic non-functioning pituitary carcinoma. Pituitary. 18(5). 710–721. 38 indexed citations
7.
Eigler, Tamar, et al.. (2014). Constitutive Somatostatin Receptor Subtype-3 Signaling Suppresses Growth Hormone Synthesis. Molecular Endocrinology. 28(4). 554–564. 17 indexed citations
8.
Chesnokova, Vera, Svetlana Zonis, Cuiqi Zhou, et al.. (2011). Lineage-Specific Restraint of Pituitary Gonadotroph Cell Adenoma Growth. PLoS ONE. 6(3). e17924–e17924. 39 indexed citations
9.
Yu, Run, Deepti Dhall, Nicholas N. Nissen, Cuiqi Zhou, & Song-Guang Ren. (2011). Pancreatic Neuroendocrine Tumors in Glucagon Receptor-Deficient Mice. PLoS ONE. 6(8). e23397–e23397. 57 indexed citations
10.
Yu, Run, Kolja Wawrowsky, & Cuiqi Zhou. (2011). A natural inactivating mutant of human glucagon receptor exhibits multiple abnormalities in processing and signaling. Endocrinología y Nutrición. 58(6). 258–266. 20 indexed citations
11.
Tong, Yunguang, Weijiang Zhao, Cuiqi Zhou, Kolja Wawrowsky, & Шломо Мелмед. (2011). PTTG1 Attenuates Drug-Induced Cellular Senescence. PLoS ONE. 6(8). e23754–e23754. 20 indexed citations
12.
Zhou, Cuiqi, Deepti Dhall, Nicholas N. Nissen, Chun‐Rong Chen, & Run Yu. (2009). Homozygous P86S Mutation of the Human Glucagon Receptor Is Associated With Hyperglucagonemia, α Cell Hyperplasia, and Islet Cell Tumor. Pancreas. 38(8). 941–946. 113 indexed citations
13.
Ben-Shlomo, Anat, Cuiqi Zhou, Vera Chesnokova, et al.. (2009). Constitutive Somatostatin Receptor Activity Determines Tonic Pituitary Cell Response. Molecular Endocrinology. 23(3). 337–348. 29 indexed citations
14.
Yan, Shuang, Cuiqi Zhou, Wei Zhang, et al.. (2008). β-Catenin/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma. Cancer Letters. 271(1). 85–97. 85 indexed citations
15.
Wang, Yihua, Xiaobo Zhou, Hongxia Zhu, et al.. (2005). Overexpression of EB1 in human esophageal squamous cell carcinoma (ESCC) may promote cellular growth by activating β-catenin/TCF pathway. Oncogene. 24(44). 6637–6645. 66 indexed citations
16.
17.
Zhou, Cuiqi, Shuang Liu, Xiaobo Zhou, et al.. (2004). Overexpression of human pituitary tumor transforming gene (hPTTG), is regulated by ?-catenin /TCF pathway in human esophageal squamous cell carcinoma. International Journal of Cancer. 113(6). 891–898. 64 indexed citations
18.
Wang, Yihua, Shuang Liu, Cuiqi Zhou, et al.. (2004). Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo. Breast Cancer Research. 7(2). R220–8. 131 indexed citations
19.
Zhu, Hongxia, Cuiqi Zhou, Xiaobo Zhou, et al.. (2003). [Survivin mutants reverse the malignancy of HeLa cells].. PubMed. 22(5). 467–70. 2 indexed citations
20.
Zhou, Cuiqi. (2003). Down-regulation of γ-synuclein in human esophageal squamous cell carcinoma. World Journal of Gastroenterology. 9(9). 1900–1900. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Iván Plaza-Menacho Breakdown of academic impact, for papers by Gabriele Jaques Breakdown of academic impact, for papers by Michele Menicagli Breakdown of academic impact, for papers by Yen K. Lieu Breakdown of academic impact, for papers by Paul Naik Breakdown of academic impact, for papers by Paolo Salerno Breakdown of academic impact, for papers by Nives Pećina‐Šlaus Breakdown of academic impact, for papers by J K Anderson Breakdown of academic impact, for papers by Cong S. Zong Breakdown of academic impact, for papers by Nicolas Gadot
Rankless by CCL
2026